General Information of the Compound
Compound ID
CP0077818
Compound Name
CL-287389
    Show/Hide
Synonyms
3,5-Pyridinedicarboxylic acid, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-methyl 5-(1-methylethyl) ester
5-Isopropyl 3-methyl 2-cyano-1,4-dihydro-6-methyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
75530-68-6
ARC029
BRN 3572609
C19H19N3O6
CL 287,389
CL-287389
Escor
F 102,362
F-102362
FAIIFDPAEUKBEP-UHFFFAOYSA-N
FK 235
FK-235
FR 34235
FR-34235
NCGC00167435-01
NILVADIPINE
Nilvadipine
Nilvadipine (ARC029)
Nilvadipine [USAN:INN:JAN]
Nilvadipino
Nilvadipino [Spanish]
Nilvadipinum [Latin]
Nivadil
Nivadipine
nilvadipine
    Show/Hide
Structure
Formula
C19H19N3O6
Molecular Weight
385.376
Canonical SMILES
COC(=O)C1=C(NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N
    Show/Hide
InChI
InChI=1S/C19H19N3O6/c1-10(2)28-19(24)15-11(3)21-14(9-20)17(18(23)27-4)16(15)12-6-5-7-13(8-12)22(25)26/h5-8,10,16,21H,1-4H3
    Show/Hide
InChIKey
FAIIFDPAEUKBEP-UHFFFAOYSA-N
CAS
75530-68-6
Physicochemical Property
logP
2.45788
Rotatable Bonds
5
Heavy Atom Count
28
Polar Areas
131.56
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 4494
SID: 14829624
ChEMBL ID
CHEMBL517427
DrugBank ID
DB06712
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000009 LLC-PK1 Sus scrofa (Pig)  1
1
IC50 = 18000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01552, Nuclear receptor subfamily 1 group I member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000514 DPX2 Homo sapiens (Human)  2
1
EC50 = 1900 nM
   TI
   LI
   LO
   TS
2
EC50 = 2000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 890 nM
Protein ID: PT04880, Nuclear receptor subfamily 1 group I member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
EC50 = 10500 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( ARC029 )
Drug Name ARC029
Company Archer Pharmaceuticals
Indication
Alzheimer disease
Phase 3
Alzheimer disease
Phase 3
Target(s)
Voltage-gated calcium channel alpha Cav1.3 (CACNA1D)
Inhibitor
Voltage-gated calcium channel alpha Cav1.2 (CACNA1C)
Inhibitor